Patrik Andersson

Dr. Patrik Andersson

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2016 in Environmental Science & Technology
Verified
Journal Article
Open access
JZJin Zhang
Jin Zhang
ABAfshan Begum
Afshan Begum
KBKristoffer Brännström
Kristoffer Brännström
CGChristin Grundström
Christin Grundström
IIIrina Iakovleva
Irina Iakovleva
PAPatrik Andersson
Patrik Andersson
Thyroid disruption by xenobiotics is associated with a broad spectrum of severe adverse outcomes. One possible molecular target of thyroid hormone disrupting chemicals (THDCs) is transthyretin (TTR), a thyroid hormone transporter in vertebrates. To better understand the interactions between TTR and THDCs, we determined the crystallographic structures of human TTR in complex with perfluorooctanesulfonic acid (PFOS), perfluorooctanoic acid (PFOA), and 2,2′,4,4′-tetrahydroxybenzophenone (BP2). The molecular interactions between the ligands and TTR were further characterized using molecular dynamics simulations. A structure-based virtual screening (VS) protocol was developed with the intention of providing an efficient tool for the discovery of novel TTR-binders from the Tox21 inventory. Among the 192 predicted binders, 12 representatives were selected, and their TTR binding affinities were studied with isothermal titration calorimetry, of which seven compounds had binding affinities between 0.26 and 100 μM. To elucidate structural details in their binding to TTR, crystal structures were determined of TTR in complex with four of the identified compounds including 2,6-dinitro-p-cresol, bisphenol S, clonixin, and triclopyr. The compounds were found to bind in the TTR hormone binding sites as predicted. Our results show that the developed VS protocol is able to successfully identify potential THDCs, and we suggest that it can be used to propose THDCs for future toxicological evaluations.

Verified
Journal Article
Open access
PDF file
JLJuliette Legler
Juliette Legler
DZDaniel Zalko
Daniel Zalko
Fabien JourdanFabien Jourdan
Fabien Jourdan
MJMiriam Naomi Jacobs
Miriam Naomi Jacobs
BFBernard Fromenty
Bernard Fromenty
Jorke KamstraJorke Kamstra
Jorke Kamstra
The purpose of this project report is to introduce the European “GOLIATH” project, a new research project which addresses one of the most urgent regulatory needs in the testing of endocrine-disrupting chemicals (EDCs), namely the lack of methods for testing EDCs that disrupt metabolism and metabolic functions. These chemicals collectively referred to as “metabolism disrupting compounds” (MDCs) are natural and anthropogenic chemicals that can promote metabolic changes that can ultimately result in obesity, diabetes, and/or fatty liver in humans. This project report introduces the main approaches of the project and provides a focused review of the evidence of metabolic disruption for selected EDCs. GOLIATH will generate the world’s first integrated approach to testing and assessment (IATA) specifically tailored to MDCs. GOLIATH will focus on the main cellular targets of metabolic disruption—hepatocytes, pancreatic endocrine cells, myocytes and adipocytes—and using an adverse outcome pathway (AOP) framework will provide key information on MDC-related mode of action by incorporating multi-omic analyses and translating results from in silico, in vitro, and in vivo models and assays to adverse metabolic health outcomes in humans at real-life exposures. Given the importance of international acceptance of the developed test methods for regulatory use, GOLIATH will link with ongoing initiatives of the Organisation for Economic Development (OECD) for test method (pre-)validation, IATA, and AOP development.

Verified
Journal Article
Open access
PDF file
DLDiana-Ioana Lupu
Diana-Ioana Lupu
PAPatrik Andersson
Patrik Andersson
CBCarl-Gustaf Bornehag
Carl-Gustaf Bornehag
BDBarbara Demeneix
Barbara Demeneix
EFEllen Fritsche
Ellen Fritsche
JRJoëlle Rüegg
Joëlle Rüegg
Ubiquitous exposure to endocrine-disrupting chemicals (EDCs) has caused serious concerns about the ability of these chemicals to affect neurodevelopment, among others. Since endocrine disruption (ED)-induced developmental neurotoxicity (DNT) is hardly covered by the chemical testing tools that are currently in regulatory use, the Horizon 2020 research and innovation action ENDpoiNTs has been launched to fill the scientific and methodological gaps related to the assessment of this type of chemical toxicity. The ENDpoiNTs project will generate new knowledge about ED-induced DNT and aims to develop and improve in vitro, in vivo, and in silico models pertaining to ED-linked DNT outcomes for chemical testing. This will be achieved by establishing correlative and causal links between known and novel neurodevelopmental endpoints and endocrine pathways through integration of molecular, cellular, and organismal data from in vitro and in vivo models. Based on this knowledge, the project aims to provide adverse outcome pathways (AOPs) for ED-induced DNT and to develop and integrate new testing tools with high relevance for human health into European and international regulatory frameworks.

1 February 2019 in Science of The Total Environment
Verified
Journal Article
Closed access
QGQiuju Gao
Qiuju Gao
KBKristin M. Blum
Kristin M. Blum
PGPablo Gago-Ferrero
Pablo Gago-Ferrero
KWKarin Wiberg
Karin Wiberg
LALutz Ahrens
Lutz Ahrens
PAPatrik Andersson
Patrik Andersson

7 July 2022 in Environmental Science & Technology
Verified
Journal Article
Open access
ICIoana Chelcea
Ioana Chelcea
SÖStefan Örn
Stefan Örn
THTimo Hamers
Timo Hamers
JKJacco Koekkoek
Jacco Koekkoek
JLJessica Legradi
Jessica Legradi
PAPatrik Andersson
Patrik Andersson
Bisphenol A (BPA) is an industrial chemical, which has raised human health and environmental concerns due to its endocrine-disrupting properties. BPA analogues are less well-studied despite their wide use in consumer products. These analogues have been detected in water and aquatic organisms around the world, with some analogues showing toxic effects in various species including fish. Here, we present novel organ-specific time-course distribution data of bisphenol Z (BPZ) in female zebrafish (Danio rerio), including concentrations in the ovaries, liver, and brain, a rarely sampled organ with high toxicological relevance. Furthermore, fish-specific in vitro biotransformation rates were determined for 11 selected bisphenols. A physiologically based toxicokinetic (PBTK) model was adapted for four of these bisphenols, which was able to predict levels in the gonads, liver, and brain as well as the whole body within a 2-5-fold error with respect to experimental data, covering several important target organs of toxicity. In particular, predicted liver concentrations improved compared to currently available PBTK models. Predicted data indicate that studied bisphenols mainly distribute to the carcass and gonads and less to the brain. Our model provides a tool to increase our understanding on the distribution and kinetics of a group of emerging pollutants.

13 July 2018 in Environmental Science & Technology
Verified
Journal Article
Closed access
CLCao Lin-Ying
Cao Lin-Ying
ZZZiye Zheng
Ziye Zheng
XRXiao-Min Ren
Xiao-Min Ren
PAPatrik Andersson
Patrik Andersson
LGLiang-Hong Guo
Liang-Hong Guo